Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreAbout
Alpha Genesis is a full-service preclinical CRO with an integrated rodent-to-NHP platform spanning GLP and non-GLP study execution, animal supply and breeding, imports and quarantine, worldwide logistics, and bioproducts. Decades of veterinary and scientific expertise, and the largest primate colony in the United States, stand behind every program.
Alpha Genesis is an integrated preclinical CRO that supports pharmaceutical, biotechnology, academic, and government sponsors from early in vivo work through IND-enabling studies. For decades we have executed rodent and NHP studies and provided the animal resources behind them: research-grade supply, contract breeding, imports and quarantine, worldwide logistics, and bioproducts, all under one organization with deep scientific expertise, consistent veterinary leadership, and accredited animal-care operations. Our programs span the United States, Europe, and Asia.
Our facilities are built for reliable study execution and long-term animal health, from rodent in vivo work to the largest primate colony in the country. Our team includes veterinarians, clinical and research scientists, study directors, colony managers, and operations staff whose work is guided by a shared commitment to animal welfare, scientific integrity, and client partnership.
The best preclinical science begins with animals that are well cared for, properly conditioned, and managed with attention to behavioral and physiological health. That philosophy shapes how we design studies, run our facilities, collect biospecimens, and support multinational development programs, from discovery and early in vivo work through translational studies, IND-enabling programs, and regulatory submission.
Alpha Genesis has been shaped over many years under the leadership of Dr. Greg Westergaard, the company’s Chief Executive Officer.
A primatologist by training, Dr. Westergaard has guided Alpha Genesis with the conviction that rigorous science and uncompromising animal welfare are inseparable. That principle, that the quality of preclinical data begins with the quality of animal care, remains the foundation of the organization’s culture.
From its roots in NHP research and colony management, Alpha Genesis has grown into an integrated preclinical partner: CRO study execution, research-grade animal supply, contract breeding, imports and quarantine, worldwide logistics, bioproducts, and, most recently, expanding rodent GLP and non-GLP study capabilities.
Alpha Genesis established itself in NHP research, breeding, and colony management, building veterinary and scientific expertise across multiple species.
Under Dr. Greg Westergaard, the organization placed animal welfare and scientific rigor at the center of every program, a culture that continues to define the company.
Capabilities expanded beyond supply and breeding into full preclinical CRO services, biospecimens, imports and quarantine, and worldwide NHP logistics.
Alpha Genesis added rodent GLP and non-GLP study capabilities, letting sponsors start in rodents and advance into NHP studies with one partner.
Our business lines operate as a coordinated platform, letting sponsors work with one experienced partner across species, study types, and program stages.
GLP and non-GLP study execution across pharmacology, PK/PD, toxicology, immunology, vaccines, and infectious disease in rodent and NHP models.
Learn moreExpanding mouse and rat in vivo capabilities for early proof-of-concept, dose-ranging, pharmacology, and tolerability studies.
Learn moreTranslationally relevant NHP pharmacology, safety, vaccine, and infectious-disease studies with veterinary oversight and sponsor audit–ready documentation.
Learn moreResearch-grade rhesus and cynomolgus macaques and African green monkeys for research clients.
Learn moreLong-term NHP breeding and colony-development programs designed to support sustained research and government client needs.
Learn moreImporting NHPs into the United States, USDA-regulated quarantine and health screening (including for third parties), and worldwide NHP export.
Learn moreWhole blood, serum, plasma, PBMCs, and tissues collected under standard or custom sponsor protocols from characterized NHP and rodent donors.
Learn moreExpanding rodent capabilities allow sponsors to begin early in vivo work at Alpha Genesis and progress into translationally relevant NHP studies without changing partners, veterinary philosophy, or documentation standards.
Early in vivo proof-of-concept, PK/PD, dose-ranging, tolerability, and screening in mouse and rat models.
Immunology, biodistribution, efficacy, and mechanism work that de-risks the program before higher-species studies.
Translationally relevant NHP pharmacology, safety, vaccine, and infectious-disease studies when the model requires it.
A single animal-welfare-centered team across species, with consistent veterinary oversight and documentation.
Six principles guide our scientific conduct, client relationships, and operational decisions.
At Alpha Genesis, animal welfare is the foundation of reliable data, ethical study conduct, regulatory confidence, and long-term client trust. Welfare and scientific rigor are inseparable.
Study design, execution, and reporting follow established scientific standards. Protocol fidelity and meticulous data collection are expectations, not aspirations.
Veterinarians lead clinical monitoring, preventive medicine, and study-level health oversight across all species and programs.
Decades of large-scale NHP program experience combined with growing rodent capabilities give sponsors a partner with the infrastructure to support complex, long-term, and multinational research programs.
We engage sponsors early in planning, communicate transparently about timelines and feasibility, and work as an extension of the research team rather than a transactional vendor.
SOP-driven operations, complete records, and ongoing audit readiness mean sponsors can rely on the documentation quality their regulatory programs require, in the United States and internationally.
An independently accredited animal-care program, IACUC oversight of every study, and SOP-driven operations form the quiet backing behind our work, supported by comprehensive record-keeping and ongoing sponsor audit readiness.
For us, these credentials are a floor, not a finish line. They reflect a long-standing organizational commitment to the welfare of animals in our care and the scientific integrity of the work performed at our facilities.
Whether you are planning an early in vivo program, evaluating NHP study options, or looking for a long-term preclinical partner, our scientific and business-development team is glad to discuss your objectives and how we can support them.
